Mary-Claire King's discovery of the BRCA1 gene has been pivotal in understanding hereditary breast cancer, yet access to genetic testing remains alarmingly low 30 years later.
Despite the advancements since 1990, we recognize that the majority of individuals at risk for BRCA1/2 mutations still lack access to necessary genetic tests.
The significant advancements made post-BRCA1 discovery demand not just awareness but also systemic change to ensure broader access to genetic testing and risk-reduction options.
Undertaking a systematic approach to improve access to genetic tests is critical for enabling those at risk to make informed health decisions.
Collection
[
|
...
]